LU85791A1 - Compositions de bromocriptine - Google Patents
Compositions de bromocriptine Download PDFInfo
- Publication number
- LU85791A1 LU85791A1 LU85791A LU85791A LU85791A1 LU 85791 A1 LU85791 A1 LU 85791A1 LU 85791 A LU85791 A LU 85791A LU 85791 A LU85791 A LU 85791A LU 85791 A1 LU85791 A1 LU 85791A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- bromocriptine
- composition according
- capsule
- fat
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8405227 | 1984-02-29 | ||
| GB848405227A GB8405227D0 (en) | 1984-02-29 | 1984-02-29 | Bromocriptine compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU85791A1 true LU85791A1 (fr) | 1985-12-11 |
Family
ID=10557324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU85791A LU85791A1 (fr) | 1984-02-29 | 1985-02-27 | Compositions de bromocriptine |
Country Status (26)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4064285A (en) * | 1984-03-21 | 1985-10-11 | American Home Products Corporation | Sustained release pharmaceutical capsules |
| DE3722383A1 (de) * | 1986-07-14 | 1988-01-28 | Sandoz Ag | Neue verwendung von bromocriptin |
| DE4041563A1 (de) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren |
| AU679511B2 (en) * | 1993-03-17 | 1997-07-03 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL265428A (US08177716-20120515-C00003.png) * | 1960-06-06 | |||
| CH507249A (de) * | 1968-05-31 | 1971-05-15 | Sandoz Ag | Verfahren zur Herstellung von 2-Brom-a-ergokryptin |
| DE2553026A1 (de) * | 1974-12-04 | 1976-06-10 | Schlueter Edelfett | Neue formulierungen |
| CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
| IT1158162B (it) * | 1977-12-22 | 1987-02-18 | Sandoz Ag | Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina |
| DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
| US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| DE3216870A1 (de) * | 1982-05-03 | 1983-11-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische zubereitungen mit zytostatischer wirkung |
| US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
-
1983
- 1983-12-14 CH CH6660/83A patent/CH666406A5/de not_active IP Right Cessation
-
1984
- 1984-02-29 GB GB848405227A patent/GB8405227D0/en active Pending
-
1985
- 1985-02-14 NL NL8500417A patent/NL194231C/nl not_active IP Right Cessation
- 1985-02-14 HU HU85555A patent/HU196121B/hu unknown
- 1985-02-20 DE DE3505743A patent/DE3505743C2/de not_active Expired - Lifetime
- 1985-02-20 IT IT47703/85A patent/IT1199948B/it active
- 1985-02-22 CH CH830/85A patent/CH667009A5/de not_active IP Right Cessation
- 1985-02-22 FR FR8502716A patent/FR2560047B1/fr not_active Expired
- 1985-02-25 BE BE1/11199A patent/BE901810A/fr not_active IP Right Cessation
- 1985-02-26 DK DK198500867A patent/DK175016B1/da active Protection Beyond IP Right Term
- 1985-02-26 CA CA000475119A patent/CA1256374A/en not_active Expired
- 1985-02-26 AU AU39136/85A patent/AU586621B2/en not_active Expired
- 1985-02-27 JP JP60040277A patent/JPS60202812A/ja active Granted
- 1985-02-27 SE SE8500961A patent/SE462259B/sv unknown
- 1985-02-27 LU LU85791A patent/LU85791A1/fr unknown
- 1985-02-27 IL IL74459A patent/IL74459A/xx not_active IP Right Cessation
- 1985-02-27 PT PT80015A patent/PT80015B/pt unknown
- 1985-02-27 SE SE8500961D patent/SE8500961L/xx not_active Application Discontinuation
- 1985-02-27 NZ NZ211247A patent/NZ211247A/xx unknown
- 1985-02-27 AT AT0058085A patent/AT387716B/de not_active IP Right Cessation
- 1985-02-27 GR GR850506A patent/GR850506B/el not_active IP Right Cessation
- 1985-02-28 IE IE49585A patent/IE58235B1/en not_active IP Right Cessation
- 1985-02-28 PH PH31923A patent/PH23266A/en unknown
- 1985-02-28 ZA ZA851546A patent/ZA851546B/xx unknown
- 1985-02-28 ES ES540807A patent/ES8705223A1/es not_active Expired
-
1989
- 1989-05-19 AU AU35006/89A patent/AU618599B2/en not_active Expired
-
1990
- 1990-08-22 SG SG693/90A patent/SG69390G/en unknown
- 1990-10-18 HK HK854/90A patent/HK85490A/xx not_active IP Right Cessation
-
1992
- 1992-06-26 MX MX9203626A patent/MX9203626A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1011045A3 (fr) | Compositions pharmaceutiques pour la liberation controlee de substances actives. | |
| BE1014328A7 (fr) | Composition pharmaceutique orale a liberation controlee. | |
| FR2737121A1 (fr) | Nouvelles formulations galeniques du fenofibrate et leurs applications | |
| FR2460667A1 (fr) | Composition pharmaceutique a liberation prolongee a base d'une substance medicamenteuse solide | |
| US8784872B2 (en) | Formulation for decreasing tobacco, alcohol, drug or food consumption | |
| CH702775B1 (fr) | Pastilles de gélatine douces contenant de la nicotine et procédé de préparation. | |
| FR2512676A1 (fr) | Composition a liberation commandee hydrodynamiquement equilibree | |
| BE1000661A4 (fr) | Nouvelles compositions pharmaceutiques a base de ketotifene. | |
| BE1000496A7 (fr) | Procede pour la production de preparations pharmaceutiques ayant une haute capacite de fixation de l'acide gastrique, exercant un effet retard et ayant une biodisponibilite accrue. | |
| EP0754033B1 (fr) | Composition galenique mucoadhesive heterofonctionnelle | |
| GB2154874A (en) | Bromocriptine compositions | |
| BE1000159A5 (fr) | Medicament a liberation controlee pour fournir des ions fluorure. | |
| BE1007024A5 (fr) | Compositions a activite agoniste des recepteurs analogues a 5ht1, selective. | |
| LU85791A1 (fr) | Compositions de bromocriptine | |
| WO2001051033A1 (fr) | Compositions pharmaceutiques solides pour la liberation controlee de substances actives | |
| BE1010972A6 (fr) | Composition pharmaceutique antituberculeuse et procede destine a produire ladite composition. | |
| FR2604902A1 (fr) | Compositions pharmaceutiques a liberation prolongee | |
| FR2576787A1 (fr) | Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle | |
| BE1000265A3 (fr) | Nouvelle association medicamenteuse. | |
| EP0413694B1 (fr) | Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur | |
| EP1465607B1 (fr) | Compositions pharmaceutiques a liberation modifiee | |
| EP0911038B1 (fr) | Composition anhydre à base de lactulose | |
| JP4945043B2 (ja) | モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤 | |
| FR2589732A1 (fr) | Nouvelle formulation a liberation prolongee a base de pindolol | |
| EP0412877A1 (fr) | Nouvelle forme galénique orale améliorant la biodisponibilité |